glp-1 based therapeutics summit Total Support – Nutritions GLP-1 therapy appears to reduce

BMJ Open 11(5):e047993

GIP has neuroprotective effects in Alzheimer and Parkinsons disease models

Data sources and methods: A systematic search of PubMed, Scopus, Web of Science, and Cochrane was conducted until March 2025

And others are looking at their role in risk of recurrence and potentially as a mechanism to slow tumor growth

It is currently conducting trials that could ultimately lead to its use in concert with GLP-1 drugs (a process known as adjunctive therapy) so patients dont lose lean muscle

Glucose-dependent insulinotropic polypeptide helps the body release insulin when you eat foods with fats and carbohydrates, which helps control your blood sugar levels